Reply to “Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma”

Katrien Eger*, Johannes A. Kroes, Anneke ten Brinke, Elisabeth H. Bel

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)1936
Number of pages1
JournalJournal of Allergy and Clinical Immunology: In Practice
Issue number7
Publication statusPublished - 1 Jul 2022

Cite this